Glucagon-Like Peptide-1 Receptor Agonists: all 1,407 studies that test it
Page 15 of 15. Open to participants first (306), then studies with results posted, then the rest; newest registration first within each.
- Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I DiabetesCompletedNCT00064714Phase 2
- Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes MellitusCompletedNCT00044694Phase 2
- Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea CombinationCompletedNCT00044668Phase 3
- Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a SulfonylureaCompletedNCT00039026Phase 3
- Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With MetforminCompletedNCT00039013Phase 3
- Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes MellitusCompletedNCT00035984Phase 3
- NNC 90-1170 Mechanism of Action: A Double-Blind, Randomized, Single-Center, Placebo-Controlled, Crossover Study to Examine Beta-Cell Responsiveness to Graded Glucose Infusion in Subjects With Type 2 DiabetesCompletedNCT00013910Phase 1